Milk-and-Dairy-Products-in-Human-Nutrition-FAO
Milk-and-Dairy-Products-in-Human-Nutrition-FAO
Milk-and-Dairy-Products-in-Human-Nutrition-FAO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 4 – <strong>Milk</strong> <strong>and</strong> dairy products as part of the diet 123<br />
be determ<strong>in</strong>ed by balance studies conducted with sufficient care, <strong>and</strong> over a sufficiently<br />
long period of time to ensure reasonable accuracy <strong>and</strong> then corrected for<br />
<strong>in</strong>sensible losses. The calcium requirement was reported to change depend<strong>in</strong>g on<br />
other nutrients present <strong>in</strong> the diet, two such nutrients be<strong>in</strong>g sodium (presumably<br />
compet<strong>in</strong>g with calcium for reabsorption <strong>in</strong> the renal tubules) <strong>and</strong> animal prote<strong>in</strong><br />
(see “Prote<strong>in</strong>”, below, for possible mechanisms), both of which <strong>in</strong>crease ur<strong>in</strong>ary<br />
calcium <strong>and</strong> were therefore presumed to <strong>in</strong>crease calcium requirement. Vitam<strong>in</strong> D<br />
also plays a role <strong>in</strong> calcium homeostasis <strong>and</strong> calcium absorption. The expert consultation<br />
also highlighted the “calcium paradox”, that hip fracture rates are higher<br />
<strong>in</strong> developed countries, where calcium <strong>in</strong>take is high, than <strong>in</strong> develop<strong>in</strong>g countries,<br />
where calcium <strong>in</strong>take is lower, 23 <strong>and</strong> suggested that this may be related to prote<strong>in</strong><br />
<strong>in</strong>take <strong>and</strong> vitam<strong>in</strong> D status <strong>in</strong> these countries, or both, with sodium <strong>in</strong>take be<strong>in</strong>g<br />
another possible reason. Hence, the expert consultation provided different recommendations<br />
for countries with low consumption of animal prote<strong>in</strong> (20–40 g/day<br />
rather than the 60–80 g/day typical of developed countries) (Table 4.3).<br />
A subsequent WHO/<strong>FAO</strong> expert consultation on diet, nutrition <strong>and</strong> the prevention<br />
of chronic diseases (WHO <strong>and</strong> <strong>FAO</strong>, 2003) concluded that there is conv<strong>in</strong>c<strong>in</strong>g<br />
evidence that sufficient <strong>in</strong>take of vitam<strong>in</strong> D <strong>and</strong> calcium together reduces the<br />
risk of osteoporotic fracture <strong>in</strong> older people. Based on the f<strong>in</strong>d<strong>in</strong>gs of <strong>FAO</strong> <strong>and</strong><br />
WHO (2002), WHO <strong>and</strong> <strong>FAO</strong> (2003) recommended a m<strong>in</strong>imum daily <strong>in</strong>take of<br />
400–500 mg of calcium <strong>in</strong> countries with a high <strong>in</strong>cidence of fracture to prevent<br />
osteoporosis (WHO <strong>and</strong> <strong>FAO</strong>, 2003). This recommendation was made after consider<strong>in</strong>g<br />
the strength of the evidence with fracture as an end po<strong>in</strong>t (rather than BMD;<br />
see Section 4.4.5 for limitations of studies us<strong>in</strong>g BMD as an end po<strong>in</strong>t), <strong>and</strong> appears<br />
to relate to older people (>50-60 yr). This is considerably lower than the amounts<br />
recommended by the previous expert consultation (Table 4.3). The experts further<br />
stated that recommendations for calcium <strong>in</strong>take <strong>in</strong> countries with low fracture<br />
<strong>in</strong>cidence should take <strong>in</strong>to account the <strong>in</strong>teraction between calcium <strong>in</strong>take, physical<br />
activity, sun exposure <strong>and</strong> <strong>in</strong>take of other dietary components (e.g. vitam<strong>in</strong> D,<br />
vitam<strong>in</strong> K, sodium, prote<strong>in</strong>) <strong>and</strong> protective phytonutrients (e.g. soy compounds).<br />
Vitam<strong>in</strong> D<br />
Calcium <strong>and</strong> vitam<strong>in</strong> D <strong>in</strong>teract <strong>in</strong> the human body: when the level of ionized calcium<br />
<strong>in</strong> the blood falls, parathyroid hormone is secreted by the parathyroid gl<strong>and</strong>,<br />
stimulat<strong>in</strong>g the conversion of vitam<strong>in</strong> D to its active form, calcitriol (1,25-dihydroxyvitam<strong>in</strong><br />
D) <strong>and</strong> thus deplet<strong>in</strong>g vitam<strong>in</strong> D status (measured by the amount of<br />
the <strong>in</strong>active form). Vitam<strong>in</strong> D, as calcitriol, <strong>in</strong>fluences calcium absorption across the<br />
<strong>in</strong>test<strong>in</strong>e, <strong>and</strong> <strong>in</strong>adequate vitam<strong>in</strong> D status is associated with reduced absorption of<br />
calcium from the diet. Vitam<strong>in</strong> D can either be made <strong>in</strong> the sk<strong>in</strong> from a cholesterollike<br />
precursor by exposure to sunlight or can be provided preformed <strong>in</strong> the diet;<br />
from a nutritional perspective, the two forms are metabolized similarly <strong>in</strong> humans,<br />
are equal <strong>in</strong> potency <strong>and</strong> can be considered equivalent (<strong>FAO</strong> <strong>and</strong> WHO, 2002).<br />
23 Average total calcium <strong>in</strong>takes <strong>in</strong> Africa, Lat<strong>in</strong> America, the Near East <strong>and</strong> the Far East are less than<br />
500 mg/day; the average total calcium <strong>in</strong>take for all develop<strong>in</strong>g countries is only 344 mg/day (<strong>FAO</strong>/<br />
WHO, 2002).